Table 1.

Patient’s clinical characteristics

Characteristics	Total case (N=13)
Male gender, n (%)	10 (76.9%)
Caucasian, n (%)	13 (100.0%)
Weight at the time of FMT, kg	72.2 ± 10.9
BMI at the time of FMT, kg/m2	24.0 ± 3.6
Ever smoked, n (%)
Current	1 (7.7%)
Quit	3 (23.1%)
Significant comorbidities, n (%)	2 (15.4%)
Concurrent autoimmune disorders, n (%)	1 (7.1%)
Family history of IBD, n (%)	4 (30.8%)
Family history of colorectal cancer, n (%)	2 (15.4%)
Age at IBD diagnosis, years	21.7 ± 12.5
Precolectomy diagnosis of UC, n (%)	13 (100.0%)
Extensive colitis, n (%)	13 (100.0%)
Primary sclerosing cholangitis, n (%)	1 (7.7 %)
Other extra-intestinal manifestation, n (%)	2 (15.4%)
Preoperative use of biologics, n (%)	4 (30.8%)
Age at colectomy, years	32.7 ± 12.6
Duration from IBD diagnosis to colectomy, years	11.0 ± 11.9
Indication for colectomy, n (%)
Refractory disease	11 (84.6%)
Neoplasia	2 (15.4%)
Stage of pouch construction, n (%)
1	2 (15.4%)
2	2 (15.4%)
3	8 (61.5%)
Redo pouch	1 (7.7%)
J configuration of the pouch, n (%)	13 (100.0%)
Postoperative leak/abscess, n (%)	5 (38.5%)
Concurrent stricture, n (%)	7 (53.8%)
Concurrent cuffitis, n (%)	5 (38.5%)
Concurrent CD of pouch, n (%)	4 (30.8%)
Age at the diagnosis of CDI, years	44.5 ± 13.8
Duration from colectomy to diagnosis of CDI, years	11.5 ± 6.9
Presenting symptoms, n (%)
Increase bowel movements	8 (61.6%)
Urgency	10 (76.9%)
Abdominal pain	8 (61.5%)
Nausea and vomiting	3 (23.1%)
Bleeding, n (%)	2 (15.4%)
Mean session of FMT, n (%)	1.7 ± 1.1
Route of FMT, n (%)
Pouchoscopy	16 (72.7%)
Esophagogastroduodenoscopy	4 (18.2%)
Self-enema	2 (9.1%)
Volume of stool administered, ml	186.9 ± 70.6
Pouchoscopy
Upper endoscopy	30.0 ± 0.0
Duration of follow-up, years	1.2 ± 1.1
Hospitalization after FMT treatment, n (%)	2 (15.4%)
Cause of diverted pouch, n (%)
Nausea and abdominal pain	2 (15.4%)
Bowel obstruction	1 (7.7%)
Ischemic pouchitis	1 (7.7%)

CDI, Clostridium difficile infection; FTM, fecal microbiota transplant; IBD, inflammatory bowel disease.